We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Roche Strengthens Presence in Point-of-Care Information Management

By LabMedica International staff writers
Posted on 18 Oct 2010
Roche (Indianapolis, IN, USA) and Medical Automation Systems, Inc. More...
(MAS; Charlottesville, VI, USA) have signed an agreement under which Roche will acquire all the assets associated with the RALS point-of-care (POC) information technology (IT) connectivity system, as well as the names "Medical Automation Systems," "MAS" and "RALS." As part of the transaction, Roche expects to retain substantially all of the MAS employees.

MAS pioneered the use of IT systems to improve the efficiency and regulatory compliance of hospital POC programs. The company's RALS POC IT connectivity system is used in over 2,000 hospitals in the United States.

As part of Roche, RALS will remain a vendor-neutral IT connectivity solution and Roche will continue to expand the number of device interfaces available, enabling customers to streamline POC management in their hospitals.

Roche Diagnostics develops and commercializes solutions in the field of serum-based laboratory and POC testing, including CoaguChek and ACCU-CHEK products used by healthcare professionals to monitor coagulation and blood glucose at the point of care. They are currently used with the RALS information management systems in healthcare facilities across the United States.

"As a global leader in POC testing, Roche is committed to helping improve the quality of patient care by providing products that support clinical decision-making," said Jack Phillips, president and CEO of Roche Diagnostics Corporation North America. "Information management plays an increasingly critical role to meet the growing needs of our POC customers. With this acquisition, we will build on our strategy to deliver integrated testing solutions to our customers."

Related Links:
Roche
Medical Automation Systems, Inc.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.